Survival with chronic myeloid leukaemia after failing milestones.

Journal Information

Full Title: Leukemia

Abbreviation: Leukemia

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests AH: Research support from Novartis, BMS, Pfizer and Incyte. SS: Research support from Novartis, BMS, and Incyte, Honoraria from Novartis, Pfizer, Roche and Incyte."

Evidence found in paper:

"Funding Funded by the ELN Foundation. Open Access funding enabled and organized by Projekt DEAL."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025